The identification of specific genes and ion channels responsible for long QT syndrome provides fundamental insights into cardiac function and enables genetic testing and targeted therapies.
Answers are grounded in this paper and cite their sources.
Supports genetic testing in long QT syndrome; leaves open mutation-specific therapy development.
Recently, there has been intense excitement in the field of cardiac arrhythmias. Molecular genetic studies have led to significant progress in characterizing molecular mechanisms underlying long QT syndrome, an inherited cardiac disorder that causes syncope, seizures, and sudden death from ventricular arrhythmias. Three long QT syndrome genes have been identified: SCN5A on 3p21-24, HERG on 7q35-36, and KVLQT1 on 11p15.5; all encode cardiac mycote ion channels. Molecular and electrophysiological characterization of these three long QT syndrome genes has led to identification of three critical electrical currents in the human heart (INa, IKr, IKa) and provides insight into our fundamental understanding of cardiac function. Genetic testing and gene-specific therapies are now available for some families with long QT syndrome.
No takes yet. Share an insight, caveat, or question.
Wang et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: